Literature DB >> 23095991

CD34+ hematopoietic stem cells mobilization, paralleled with multiple cytokines elevated in patients with HBV-related acute-on-chronic liver failure.

Zhihong Wan1, Shaoli You, Yihui Rong, Bing Zhu, Aimin Zhang, Hong Zang, Long Xiao, Guoming Xie, Shaojie Xin.   

Abstract

BACKGROUND: Recent studies indicate that bone marrow (BM)-derived stem cells contribute to liver regeneration. But limited information is available on the dynamic and mechanisms of mobilization of BM-derived hematopoietic stem cells (HSCs) after acute-on-chronic liver failure (ACLF). AIMS: The purpose of this study was to assess the mobilization of BM-derived CD34+ HSCs in ACLF patients, and elucidate the association of stress-induced cytokines in HSCs mobilization and/or liver repair in ACLF patients.
METHODS: Thirty patients with HBV-related ACLF, 30 patients undergoing chronic hepatitis B, and 20 healthy controls were enrolled. The percentages of peripheral blood CD34+ cells were determined by two-color flow cytometry. The hepatic commitment of mobilized CD34+ cells was investigated by RT-PCR. The serum levels of stress-induced cytokines were determined by enzyme-linked immunosorbent assays.
RESULTS: A significant increase of circulating CD34+ cells was observed in ACLF patients. RT-PCR analyses showed that the mobilized CD34+ cells expressed both CD34 mRNA and liver-specific markers including cytokeratin 19 and α-fetoprotein. In parallel with mobilization of BM-derived CD34+ cells, elevated serum levels of hepatocyte growth factor, interleukin-6, stem cell factor, granulocyte colony-stimulating factor and matrix metalloproteinase 9 were observed in ACLF patients.
CONCLUSION: We demonstrated that ACLF led to mobilization of CD34+ cells, which had a hepatic differentiation potential.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23095991     DOI: 10.1007/s10620-012-2458-z

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  36 in total

1.  CD133+ stem cell mobilization after partial hepatectomy depends on resection extent and underlying disease.

Authors:  Maria Assunta Zocco; Anna Chiara Piscaglia; Felice Giuliante; Vincenzo Arena; Marialuisa Novi; Emanuele Rinninella; Annalisa Tortora; Carlo Rumi; Gennaro Nuzzo; Fabio Maria Vecchio; Giuseppe Bombardieri; Antonio Gasbarrini
Journal:  Dig Liver Dis       Date:  2010-08-04       Impact factor: 4.088

2.  Autologous CD34+ and CD133+ stem cells transplantation in patients with end stage liver disease.

Authors:  Hosny Salama; Abdel-Rahman N Zekri; Abeer A Bahnassy; Eman Medhat; Hanan A Halim; Ola S Ahmed; Ghada Mohamed; Sheren A Al Alim; Ghada M Sherif
Journal:  World J Gastroenterol       Date:  2010-11-14       Impact factor: 5.742

3.  Human hepatic stem-like cells isolated using c-kit or CD34 can differentiate into biliary epithelium.

Authors:  H A Crosby; D A Kelly; A J Strain
Journal:  Gastroenterology       Date:  2001-02       Impact factor: 22.682

4.  G-CSF-primed hematopoietic stem cells or G-CSF per se accelerate recovery and improve survival after liver injury, predominantly by promoting endogenous repair programs.

Authors:  Evangelia Yannaki; Evangelia Athanasiou; Angeliki Xagorari; Varnavas Constantinou; Ioannis Batsis; Panagiotis Kaloyannidis; Evangelia Proya; Achilles Anagnostopoulos; Athanasios Fassas
Journal:  Exp Hematol       Date:  2005-01       Impact factor: 3.084

5.  G-CSF enhanced SDF-1 gradient between bone marrow and liver associated with mobilization of peripheral blood CD34+ cells in rats with acute liver failure.

Authors:  Yan Lei; Zhengwen Liu; Qunying Han; Wen Kang; Lei Zhang; Sai Lou
Journal:  Dig Dis Sci       Date:  2009-03-18       Impact factor: 3.199

6.  Mobilization of peripheral blood hematopoietic stem cells following liver resection surgery.

Authors:  Giustina De Silvestro; Maria Vicarioto; Carla Donadel; Marinella Menegazzo; Piero Marson; Augusto Corsini
Journal:  Hepatogastroenterology       Date:  2004 May-Jun

Review 7.  Matrix metalloproteinases and their inhibitors as markers of inflammation and fibrosis in chronic liver disease (Review).

Authors:  M Consolo; A Amoroso; D A Spandidos; M C Mazzarino
Journal:  Int J Mol Med       Date:  2009-08       Impact factor: 4.101

8.  Controlled trials in hepatitis B virus-related decompensate liver cirrhosis: peripheral blood monocyte transplant versus granulocyte-colony-stimulating factor mobilization therapy.

Authors:  Y Han; L Yan; G Han; X Zhou; L Hong; Z Yin; X Zhang; S Wang; J Wang; A Sun; Z Liu; H Xie; K Wu; J Ding; D Fan
Journal:  Cytotherapy       Date:  2008       Impact factor: 5.414

9.  Mobilization of hematopoietic progenitor cells in patients with liver cirrhosis.

Authors:  Ursula M Gehling; Marc Willems; Kathleen Schlagner; Ralf A Benndorf; Maura Dandri; Jörg Petersen; Martina Sterneck; Joerg-Matthias Pollok; Dieter K Hossfeld; Xavier Rogiers
Journal:  World J Gastroenterol       Date:  2010-01-14       Impact factor: 5.742

10.  Albumin-expressing hepatocyte-like cells develop in the livers of immune-deficient mice that received transplants of highly purified human hematopoietic stem cells.

Authors:  Xiuli Wang; Shundi Ge; George McNamara; Qian-Lin Hao; Gay M Crooks; Jan A Nolta
Journal:  Blood       Date:  2003-01-30       Impact factor: 22.113

View more
  7 in total

Review 1.  Stem Cell-Based Therapies for Liver Diseases: An Overview and Update.

Authors:  Jie Wang; Meiyan Sun; Wei Liu; Yan Li; Miao Li
Journal:  Tissue Eng Regen Med       Date:  2019-02-21       Impact factor: 4.169

2.  Multiple courses of G-CSF in patients with decompensated cirrhosis: consistent mobilization of immature cells expressing hepatocyte markers and exploratory clinical evaluation.

Authors:  Silvia Gaia; Antonella Olivero; Antonina Smedile; Marco Ruella; Maria Lorena Abate; Maurizio Fadda; Emanuela Rolle; Paola Omedè; Paola Bondesan; Roberto Passera; Alessandra Risso; Manuela Aragno; Alfredo Marzano; Alessia Ciancio; Mario Rizzetto; Corrado Tarella
Journal:  Hepatol Int       Date:  2013-10-11       Impact factor: 6.047

3.  Effects of Granulocyte Colony-Stimulating Factor on Patients with Liver Failure: a Meta-Analysis.

Authors:  Qiao Yang; Ying Yang; Yu Shi; Fangfang Lv; Jiliang He; Zhi Chen
Journal:  J Clin Transl Hepatol       Date:  2016-06-15

4.  Circulating CD34+ hematopoietic stem/progenitor cells paralleled with level of viremia in patients chronically infected with hepatitis B virus.

Authors:  Hussein Abdellatif
Journal:  Regen Med Res       Date:  2018-02-20

Review 5.  Mesenchymal Stem Cell Transplantation for Liver Cell Failure: A New Direction and Option.

Authors:  Yantian Cao; Bangjie Zhang; Rong Lin; Qingzhi Wang; Jie Wang; Fangfang Shen
Journal:  Gastroenterol Res Pract       Date:  2018-03-04       Impact factor: 2.260

6.  Longitudinal effects of modified creatinine index on all-cause mortality in individuals receiving hemodialysis treatment.

Authors:  Koray Uludag; Tamer Arikan
Journal:  Ann Saudi Med       Date:  2021-12-02       Impact factor: 1.526

7.  Effectiveness of granulocyte colony-stimulating factor for patients with acute-on-chronic liver failure: a meta-analysis.

Authors:  Wei Huang; Yuanji Ma; Lingyao Du; Shuang Kang; Chang-Hai Liu; Lang Bai; Xuezhong Lei; Hong Tang
Journal:  Ann Saudi Med       Date:  2021-12-02       Impact factor: 1.526

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.